ArticleBlood advances2022

Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.

Francesca Lorentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.